Page last updated: 2024-08-21

thiazoles and Cancer of Prostate

thiazoles has been researched along with Cancer of Prostate in 156 studies

Research

Studies (156)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (2.56)	18.7374
1990's	8 (5.13)	18.2507
2000's	78 (50.00)	29.6817
2010's	59 (37.82)	24.3611
2020's	7 (4.49)	2.80

Authors

Authors	Studies
Duarte, D; Vale, N	1
Čanović, P; Jevtić, V; Jovičić Milić, S; Kačániová, M; Kočović, A; Nikolić, I; Petrović, Đ; Radojević, I; Raković, I; Simić, D; Stojković, D; Vukić, M; Vuković, N; Zarić, M; Živković-Zarić, R	1
Granados-Soler, JL; Hewicker-Trautwein, M; Klose, K; Murua Escobar, H; Nolte, I; Packeiser, EM	1
Bai, Y; Gang, X; Huang, H; Karnes, RJ; Lv, Q; Ma, L; Pan, Y; Wu, Q; Yan, Y; Yang, Y; Zhang, J	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
A Lobaccaro, JM; Baron, S; Bayala, B; Buñay, J; Figueredo, G; Guenné, S; Mahoukèdè Zohoncon, T; Nadembega, C; Simpore, J; Wendkuuni Djigma, F; Yonli, A	1
Li, Q; Luo, J; Shang, Z; Yang, Y; Zhang, B; Zhang, M	1
Ajiro, M; Alqasem, AA; Clark, B; Hagiwara, M; Iida, K; Ladomery, MR; Li, L; Oltean, S; Perks, CM; Porazinski, SR; Uzor, S; Wilson, ID	1
Doganlar, O; Doganlar, ZB; Erdogan, S; Serttas, R; Turkekul, K	1
Beer, TM; Daughety, MM; DeLoughery, TG; Olson, SR; Shatzel, JJ	1
Ciotkowska, A; Gratzke, C; Hennenberg, M; Herlemann, A; Rutz, B; Sterr, CM; Stief, CG; Strittmatter, F; Wang, X; Wang, Y; Yu, Q	1
Ban, F; Carlson, ML; Cherkasov, A; Dalal, K; Duong, F; LeBlanc, E; Li, H; Morin, H; Ong, CJ; Peacock, J; Perez, C; Rennie, PS; Roshan-Moniri, M; Sharma, A; Shepherd, A; Tam, KJ	1
Antman, EM; Babilonia, NA; Braunwald, E; Duggal, A; Fanola, CL; Giugliano, RP; Jin, J; Kamphuisen, PW; Mercuri, MF; Murphy, SA; Ruff, CT; Sritara, P	1
Aghaei, M; Azizi, R; Fallahian, F; Salemi, Z	1
Barbieri, CE; Blattner, M; Bond, R; Chew, SA; Coarfa, C; Demichelis, F; Eedunuri, VK; Geng, C; He, B; Li, C; Lonard, DM; Mitsiades, N; O'Malley, BW; Rubin, MA; Shou, J; Xu, L; Zhou, P; Zimmermann, M	1
Beumer, JH; Chatta, GS; Chen, CS; Christner, SM; Kraft, AS; Lilly, MB; Mitsuhashi, M; Twardowski, PW; Ye, W	1
Fu, W; Hu, L; Zhu, W	1
Jiang, Y; Khan, M; Meng, F; Yang, C; Yang, H; Yang, J; Yu, B; Zhou, Y	1
Eng, KH; Gao, L; Gelman, IH; Gillard, B; Su, B	1
Chen, YT; Hu, P; Huang, WC; Li, X	1
Al-Husein, B; DeRemer, DL; Goc, A; Katsanevas, K; Lou, U; Sabbineni, H; Somanath, PR; Steinbach, A	1
Adomat, H; Ban, F; Cherkasov, A; Dalal, K; Frewin, K; Leblanc, E; Li, H; Ma, D; Rennie, PS	1
Ban, F; Cherkasov, A; Dalal, K; Dehm, S; Hessein, M; Hsing, M; LeBlanc, E; Li, H; Rennie, PS; Roshan-Moniri, M; Sharma, A; Singh, K; Tomlinson Guns, ES	1
Agarwal, C; Agarwal, R; Deep, G; Nambiar, DK; Singh, RP	1
Aleksic, T; Esashi, F; Gao, S; Lodhia, KA; Macaulay, VM	1
Al-Harbi, NO; Amr, Ael-G; Bahashwan, SA; Fayed, AA; Ramadan, MA	1
Lewinska, A; Rzeszutek, I; Siwak, J; Wnuk, M	1
Guh, JH; Hsu, JL; Hsu, JT; Kudryavtsev, KV; Liu, SP; Yu, CC	1
Bharali, DJ; Cui, H; Hariri, W; Mousa, SA; Sudha, T	1
Fernández-Martínez, AB; Lucio-Cazaña, J	1
Li, Y; Luo, P; Pei, H; Sun, X; Yu, J; Zhang, J	1
Chen, C; Chen, G; Chen, QH; Wang, G; Wang, R; Zhang, C; Zhang, Q; Zhang, X; Zheng, S; Zhong, Q	1
Basu, HS; Church, DR; Huang, SX; Huang, Y; Ingenhorst, G; Ju, J; Liu, T; Lohman, JR; Ma, M; Shen, B; Tang, GL; Wilding, G; Yang, D; Yun, BS	1
Chung, LW; Huang, WC; Li, X; Wu, JB	1
Jia, Y; Liu, S; Liu, X; Pan, W; Tian, C; Wang, H; Wang, Y; Yan, J	1
Burris, TP; Cunningham, DM; Ge, D; Huang, F; Liu, S; Ma, L; You, Z; Zhang, Q	1
Egorin, MJ; Eiseman, JL; Guo, J; Joseph, E; Lazo, JS; Parise, RA; Prochownik, EV	1
Addo, SN; Slaton, JW; Sloper, DT; Tian, D; Wang, L; Xing, C	1
Cowell, S; Guns, E; Mutarapat, T; Nelson, C; Nijmeijer, S; Renaud, M; Ruchirawat, S; Sanderson, T; Scholten, D; van den Berg, M	1
Bonnelye, E; Clézardin, P; Le Gall, C	1
Bianco, S; Lanvin, O; Teyssier, C; Vanacker, JM	1
Fan, JH; He, DL; Li, L; Li, X; Wang, XY; Wu, DP; Wu, KJ; Zhang, LL	1
Saad, F	1
Barry, WT; Febbo, PG; Guinney, J; Mendiratta, P; Mostaghel, E; Nelson, PS; Porrello, A; Tewari, AK	1
Brunton, VG; Edwards, J; Leung, HY; Mitchell, TJ; Seywright, M; Tatarov, O	1
Bukhryakov, K; Gakh, AA; Gezentsvey, Y; Godovykh, E; Karapetian, R; Konstantinov, I; Krasavin, M; Lavrovsky, Y; Soldatkina, O; Sosnov, AV	1
Brown, LG; Corey, E; Koreckij, T; Nguyen, H; Vessella, RL; Yu, EY	1
Araujo, JC; Corn, P; Darnay, BG; Lee, F; Logothetis, CJ; Parikh, NU; Poblenz, A; Starbuck, MW; Thompson, JT	1
Cheng, XD; Hao, X; Hu, XB; Su, MQ; Yang, L; Yin, Y; Yue, QH; Zhou, TC	1
Ortega, A; Parra, E; Saenz, L	1
Calabrò, F; Cheng, S; Culine, S; Gross, M; Hudes, G; Massard, C; Morris, MJ; Paliwal, P; Posadas, E; Sternberg, CN; Trudel, GC; Wilding, G; Yu, EY	1
Barcia, E; Fernández-Carballido, A; Montejo, C; Negro, S	1
Li, F; Li, W; Lu, Y; Mahato, RI; Miller, DD	1
An, QX; Chen, R; Huang, XF; Mu, SJ; Wu, DC; Xia, AJ; Zhang, XQ	1
Li, SH; Pang, B; Qian, XL; Shi, QG; Wang, J; Wang, LL; Wu, RQ; Xie, BX; Yu, L; Zhang, H; Zhou, JG	1
Earp, HS; Gioeli, D; Karaca, M; Liu, Y; Whang, YE; Zhang, Z	1
Li, J; Li, W; Panzhinskiy, EE; Tong, C; Wang, J; Yeung, ED; Zhang, X	1
Abdulkadir, SA; Kim, J; Roh, M	1
Chang, PL; Feng, TH; Juang, HH; Lin, YF; Tsui, KH	1
Bénard, A; Derenne, A; Gasper, R; Goormaghtigh, E; Kiss, R; Mijatovic, T	1
Berdyshev, E; Leclercq, T; Lim, KG; Long, JS; Loveridge, C; Natarajan, V; Pitson, SM; Pyne, NJ; Pyne, S; Tate, RJ; Tonelli, F	1
Ahn, S; Dalton, JT; Kearbey, JD; Li, CM; Li, W; Lu, Y; Miller, DD; Narayanan, R; Parke, DN; Wang, Z	1
Babic, I; Cai, H; Huang, J; Wei, X; Witte, ON	1
Carducci, MA; Culine, S; Fizazi, K; Gross, ME; Hudes, G; Massard, C; Paliwal, P; Posadas, EM; Sternberg, CN; Trudel, GC; Wilding, G; Yu, EY	1
Huang, J; Wang, K; Wang, P; Zhang, TL; Zou, XM	1
Ban, JO; Han, SB; Hong, JT; Kang, KW; Moon, DC; Oh, JH; Son, SM; Song, HS; Song, MJ; Won, D	1
An, Y; Han, J; Lei, T; Li, X; Liu, J; Pan, X; Pan, Y; Ren, H; Teng, B; Wang, J; Xiao, Y; Yu, H; Zhang, J	1
Corn, PG; Dayyani, F; Gallick, GE; Logothetis, CJ	1
Agrawal, S; Araujo, JC; Armstrong, AJ; Braud, EL; Gallick, GE; Logothetis, CJ; Lonberg, M; Mathew, P; Paliwal, P; Posadas, E; Trudel, GC	1
Lepler, S; Pampo, C; Rice, L; Siemann, DW	1
Agarwal, N; Sonpavde, G; Sternberg, CN	1
Gao, X; Li, Y; Su, X; Zhang, H	1
't Hooft, KW; Guerin, VJ; L'Eplattenier, HF; Petite, AF	1
Berman, DM; Davicioni, E; Erho, N; Ghadessi, M; Gurel, B; Huang, Z; Hurley, PJ; Jenkins, RB; Marchionni, L; Miller, RM; Park, BH; Peskoe, SB; Platz, EA; Ross, AE; Schaeffer, EM; Simons, BW; Vergara, IA	1
Blackburn, TJ; Coffey, K; Cook, S; Golding, BT; Griffin, RJ; Hardcastle, IR; Hewitt, L; Huberman, K; McNeill, HV; Newell, DR; Robson, CN; Roche, C; Ryan-Munden, CA; Watson, A	1
Gleave, ME; Loriot, Y; Zoubeidi, A	1
Alossaimi, M; Bittman, R; Chan, E; Pyne, NJ; Pyne, S; Tate, RJ; Tonelli, F; Watson, DG; Williamson, L	1
Chetram, M; Hinton, C; Mezencev, R; Neal, CL; Odero-Marah, VA; Smith, BA; Vo, B	1
Bedolla, R; Ghosh, R; Kumar, AP; Li, G; Reddick, RL; Rivas, P; Thapa, D	1
Carboni, JM; Chatterji, T; Dayyani, F; Gallick, GE; Gottardis, MM; Logothetis, CJ; Maity, SN; Moorthy, S; Parikh, NU; Song, JH; Varkaris, AS; Wolfe, AR	1
Araujo, JC; Chatterji, T; Dayyani, F; Gallick, GE; Logothetis, CJ; Song, JH; Trudel, GC; Varkaris, A	1
Dosoretz, A; Holland, JF; Kirschenbaum, A; Levine, AC; Liu, XH; Lu, M; Yao, S	1
Eeckman, F; Johnson, PH; Jones, SW; Luke, MM; McCarrick, MA; Meurer, J; Monforte, J; Morgan, TK; Parry, G; Stephens, K; Tan, Y; Walker, RP; Wong, L; Zajchowski, DA	1
de Miguel, F; Gao, AC; Gerber, L; Hou, M; Lee, SO; Lou, W	1
Dewhirst, MW; Huang, Q; Li, CY; Li, Y; Wang, H; Yan, B; Zhang, X	1
Iyengar, S; Peehl, DM; Roberts, RL; Shappell, SB; Xu, Y	1
Bae, I; Cho, CH; Goldberg, ID; Jeon, KI; Kim, HJ; Lee, YJ; Rih, JK; Rosen, EM	1
Bonnefoy, JY; De Pinieux, G; Debré, B; Fridman, WH; Lebel-Binay, S; Pagès, F; Thiounn, N; Vieillefond, A	1
TRUINI, F	1
Chen, SS; Heber, D; Ikezoe, T; Koeffler, HP; Taguchi, H; Yang, Y	1
Bianchi, A; Caraci, F; Chiechio, S; Chisari, M; Frasca, G; Pinto, A; Salomone, S; Sortino, MA	1
Becker, G; Braun, K; Corban-Wilhelm, H; Debus, J; Ehemann, V; Greulich, D	1
Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ	1
Ehrenborg, E; Gustafsson, MC; Harris, AL; Jarvis, M; Knight, D; Marshall, BR; Palmer, CN; Stephen, RL; Tatoud, R; Wolf, CR	1
Oberley, TD; Webber, MM; Yan, T; Zhong, W	1
Huang, WJ; Kan, SF; Lin, LC; Wang, PS	1
Chang, C; Hu, YC; Lin, HK; Wang, L; Xie, S; Yang, L	1
Ansell, I; Bollina, P; Habib, FK; Ross, JA; Royle, JS; Tulloch, DN	1
Hu, H; Jiang, C; Lü, J; Malewicz, B; Wang, Z	1
Adhami, VM; Ahmad, N; Aziz, MH; Mukhtar, H; Nihal, M; Reagan-Shaw, SR	1
Limonta, P; Montagnani Marelli, M; Moretti, RM; Motta, M; Sala, A	1
Golovko, O; Lou, YR; Nazarova, N; Qiao, S; Tuohimaa, P	1
Dalton, JT; Gududuru, V; Hurh, E; Miller, DD	2
Guh, JH; Huang, DM; Huang, YT; Kung, FL; Shen, YC; Teng, CM; Wu, C	1
Chen, IL; Guh, JH; Huang, DM; Huang, YT; Teng, CM; Tzeng, CC	1
Chung, LW; Hsieh, CL; Jin, F; Kuo, CJ; Xie, Z	1
Baumforth, KR; Bouchal, J; Kolár, Z; Murray, PG; Sváchová, M; von Angerer, E	1
Budagova, KR; Gabai, VL; Sherman, MY	1
Abderrahmani, A; Haefliger, JA; Leisinger, HJ; Martin, D; Tawadros, T; Waeber, G	1
Cardile, V; Garbarino, JA; Lombardo, L; Russo, A; Vanella, A; Vanella, L	1
Gong, L; Hu, HY; Liu, XX; Zhang, B; Zhang, Y	1
Estes, N; Gondi, CS; Gujrati, M; Jutla, A; Lakka, SS; Pulukuri, SM; Rao, JS	1
Buettner, R; Cheng, JQ; Jove, R; Kim, D; Lee, FY; Lee, JH; Mirosevich, J; Nam, S; Zhang, S	1
Davis, JJ; Dong, F; Fang, B; Guo, W; Inoue, S; Teraishi, F; Wu, S; Zhang, L	1
Gao, X; Hu, D; Jin, L; Song, B; Xu, R; Yang, S; Zhang, G; Zhang, S	1
Davis, DA; Hussain, M; Li, Y; Sarkar, FH; Sarkar, SH	1
Chen, J; Dong, J; Jing, Y; Lu, M	1
Shen, SR; Yin, JJ; Yu, HN	1
Gürsoy, E; Güzeldemirci, NU	1
Cheung, M; Fukuyama, T; Han, FS; Osajima, H; Tokuyama, H	1
Chodyński, M; Fitak, H; Kutner, A; Opolski, A; Wietrzyk, J; Wojdat, E	1
Bruno, RD; Chopra, P; Clement, OO; Gediya, LK; Khandelwal, A; Maheshwari, N; Njar, VC; Purushottamachar, P; Vasaitis, TS	1
Fizazi, K	1
Cheng, SY; Dong, K; Gao, P; Lin, F; Wang, R; Wang, X; Wei, SH; Zhang, HZ	1
Auzenne, E; Evans, R; Farquhar, D; Ghosh, SC; Hail, N; Klostergaard, J; Leroux, ME; McDonnell, T; Spohn, W	1
Clark, E; Huang, F; Lee, F; Luo, FR; Reeves, K; Wang, XD; Xu, LA	1
Barrett, YC; Blackwood-Chirchir, A; Camuso, A; Fager, K; Galbraith, S; Lee, FY; Luo, FR; McGlinchey, K; Palme, H; Smykla, R; Wen, ML; Wild, R; Yang, Z	1
Araujo, JC; Gallick, GE; Gelovani, JG; Kim, SJ; Najjar, AM; Park, SI; Phillips, KA; Volgin, AY; Wang, Z; Zhang, J	1
Andre, JG; Foury, O; Joly-Pharaboz, MO; Mebarki, F; Morel, Y; Nicolas, B; Renaud, M; Soave, MC	1
Giammar, D; Gilloteaux, J; Jamison, JM; Summers, JL; Venugopal, M	1
Bradshaw, TD; Paull, KD; Schultz, RJ; Shi, DF; Stevens, MF; Wrigley, S	1
Asou, H; Holden, S; Koeffler, HP; Koshizuka, K; Kubota, T; Miyoshi, I; Said, JW; Williamson, EA	1
Drebin, JA; Greene, MI; Montone, KT; Murali, R; Peavey, JE; Wang, Q; Zhang, H	1
Aiyer, A; Demetri, G; Eng, C; Figg, WD; Kantoff, PW; Kaufman, DS; Kroll, T; Mueller, E; Oh, W; Sarraf, P; Smith, M; Spiegelman, BM; Zhou, XP	1
Carey, M; Hisatake, JI; Holden, S; Ikezoe, T; Koeffler, HP; Tomoyasu, S	1
Howell, SB	1
Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R	1
Lin, H; Longo, DL; Morin, PJ; Sasaki, CY	1
Boeglin, WE; Brash, AR; Case, T; Dubois, RN; Gupta, RA; Jack, GS; Manning, S; Matusik, RJ; Price, J; Schneider, C; Shappell, SB; Wheeler, TM; Whitehead, R	1
Hagopian, K; Oberley, TD; Ripple, MO; Schatten, H; Weindruch, R	1
Limonta, P; Marelli, MM; Monestiroli, S; Moretti, RM; Motta, M; Polizzi, D; Pratesi, G	1
Kantoff, PW; Kennedy, A; Majeed, N; Padley, RJ; Pollak, M; Tolcher, AW	1
Limonta, P; Montagnani Marelli, M; Moretti, RM; Motta, M	1
Chi, K; Conklin, BS; Cooper, S; Gleave, ME; Miyake, H; Monia, BP; Zellweger, T	1
Dall'Era, MA; Evans, CP; Juarez, J; Stapp, EC; Yang, JC	1
Bruchovsky, N; Sadar, MD; Ueda, T	1
Chang, SG; Jung, JC; Kim, SA; Rho, YS; Shin, CC	1
Isogawa, Y; Kakehi, Y; Kamoto, T; Kinoshita, H; Mizutani, Y; Ogawa, O; Terachi, T; Wu, XX	1
Belldegrun, A; Berger, F; Black, ME; Gambhir, SS; Matherly, J; Nguyen, D; Pantuck, AJ; Wu, L; Zisman, A	1
Kantoff, PW; Smith, MR	1
Isshiki, K; Kubota, H; Nishimoto, F; Usuda, M; Yamashoji, S	1
Cheng, AL; Mitchen, J; Oberley, T; Rago, R; Wilding, G	1
Black, J; Ip, MM; Shea, WK	1
Romijn, JC; Schroeder, FH; Verkoelen, CF	1
Ip, MM; Schenkel, L; Sylvester, PW	1

Reviews

10 review(s) available for thiazoles and Cancer of Prostate

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Management of Anticoagulation in Patients With Prostate Cancer Receiving Enzalutamide. Journal of oncology practice, 2017, Volume: 13, Issue:11 Topics: Androgen Receptor Antagonists; Anticoagulants; Atrial Fibrillation; Benzamides; Dabigatran; Drug Interactions; Embolism; Heart Valve Prosthesis; Heparin, Low-Molecular-Weight; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin	2017
Cathepsin K inhibitors as treatment of bone metastasis. Current opinion in supportive and palliative care, 2008, Volume: 2, Issue:3 Topics: Azepines; Benzamides; Biphenyl Compounds; Bone Neoplasms; Bone Remodeling; Bone Resorption; Breast Neoplasms; Cathepsin K; Cathepsins; Female; Humans; Male; Osteoclasts; Piperazines; Prostatic Neoplasms; Sulfones; Thiazoles	2008
Src as a therapeutic target in men with prostate cancer and bone metastases. BJU international, 2009, Volume: 103, Issue:4 Topics: Antineoplastic Agents; Benzodioxoles; Bone Neoplasms; Dasatinib; Humans; Male; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Quinazolines; Receptors, Androgen; src-Family Kinases; Thiazoles	2009
Novel therapies for metastatic castrate-resistant prostate cancer. Journal of the National Cancer Institute, 2011, Nov-16, Volume: 103, Issue:22 Topics: Androstenes; Androstenols; Angiogenesis Inhibitors; Anilides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Atrasentan; Benzamides; Bevacizumab; Biomarkers, Tumor; Bone Remodeling; Cancer Vaccines; Clinical Trials as Topic; Clusterin; Dasatinib; Denosumab; Endothelin-1; Humans; Immunotherapy; Indoles; Ipilimumab; Male; Mice; Mice, SCID; Molecular Targeted Therapy; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrroles; Pyrrolidines; RANK Ligand; Receptor Cross-Talk; Receptors, Androgen; Signal Transduction; Sunitinib; Taxoids; Thiazoles; Tissue Extracts; Treatment Failure; Tumor Microenvironment; Xenograft Model Antitumor Assays	2011
Novel molecular targets for the therapy of castration-resistant prostate cancer. European urology, 2012, Volume: 61, Issue:5 Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic	2012
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptor. The Urologic clinics of North America, 2012, Volume: 39, Issue:4 Topics: Bone Neoplasms; Cell Proliferation; Cell Survival; Dasatinib; Disease Progression; DNA Repair; Epothilones; Gene Fusion; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Pyrimidines; Receptors, Androgen; Taxoids; Thiazoles	2012
The role of Src in prostate cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:11 Topics: Animals; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Dasatinib; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Risk Assessment; Sensitivity and Specificity; Signal Transduction; src-Family Kinases; Thiazoles; Treatment Outcome	2007
Resistance to apoptosis in prostate cancer cells. Molecular urology, 2000,Fall, Volume: 4, Issue:3 Topics: Androgen Antagonists; Androgens; Apoptosis; Benzothiazoles; Caspases; DNA Repair; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Male; Micrococcus; Prostatic Neoplasms; Thiazoles; Toluene; Tumor Suppressor Protein p53	2000
Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer. Investigational new drugs, 2002, Volume: 20, Issue:2 Topics: Antineoplastic Agents; Chromans; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone	2002

Trials

6 trial(s) available for thiazoles and Cancer of Prostate

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy. Anti-cancer drugs, 2013, Volume: 24, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Dasatinib; Disease-Free Survival; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Pyrimidines; Testosterone; Thiazoles; Treatment Outcome	2013
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Proliferation; Dasatinib; Disease Progression; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Outcome	2009
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer. Urology, 2011, Volume: 77, Issue:5 Topics: Aged; Aged, 80 and over; Dasatinib; Drug Administration Schedule; Drug Resistance, Neoplasm; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles	2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study. Cancer, 2012, Jan-01, Volume: 118, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Castration; Dasatinib; Docetaxel; Drug Administration Schedule; Humans; Male; Maximum Tolerated Dose; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrimidines; Taxoids; Thiazoles	2012
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 2000, Sep-26, Volume: 97, Issue:20 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Division; Chromans; Humans; Ligands; Male; Middle Aged; Mutation; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured	2000

Other Studies

141 other study(ies) available for thiazoles and Cancer of Prostate

Article	Year
Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines. International journal of molecular sciences, 2021, Nov-05, Volume: 22, Issue:21 Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell-Penetrating Peptides; Clotrimazole; Colonic Neoplasms; Drug Synergism; Fluorouracil; Humans; Male; Paclitaxel; Prostatic Neoplasms; Thiazoles	2021
Newly synthesized palladium(II) complexes with aminothiazole derivatives: Dalton transactions (Cambridge, England : 2003), 2022, Jan-17, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Humans; Male; Palladium; Prostatic Neoplasms; Thiazoles; Underage Drinking	2022
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines. Veterinary and comparative oncology, 2022, Volume: 20, Issue:3 Topics: Adenocarcinoma; Animals; Benzamides; Carcinoma, Transitional Cell; Cell Line; Dog Diseases; Dogs; Male; Piperidines; Prostatic Neoplasms; Proto-Oncogene Proteins c-kit; Pyridines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Thiazoles	2022
Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer. Theranostics, 2019, Volume: 9, Issue:17 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Forkhead Box Protein O1; Humans; Male; Mice; Mice, Nude; Mice, SCID; Mutation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; PTEN Phosphohydrolase; Taxoids; Tetrazolium Salts; Thiazoles	2019
Chemical Composition, Antioxidant and Cytotoxic Activities of Pakistan journal of biological sciences : PJBS, 2020, Volume: 23, Issue:9 Topics: Antioxidants; Burkina Faso; Cations; Cell Line, Tumor; Female; Flow Cytometry; Free Radicals; Gas Chromatography-Mass Spectrometry; HeLa Cells; Humans; Hyptis; In Vitro Techniques; Inhibitory Concentration 50; Male; Monoterpenes; Oils, Volatile; Plant Extracts; Prostatic Neoplasms; Sesquiterpenes; Tetrazolium Salts; Thiazoles; Uterine Cervical Neoplasms	2020
TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK/GSK3β/SNAIL pathway. Biochemical and biophysical research communications, 2021, 03-26, Volume: 546 Topics: Animals; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3 beta; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Metastasis; Phosphorylation; Prognosis; Prostatic Neoplasms; Quinolines; Snail Family Transcription Factors; Thiazoles; Xenograft Model Antitumor Assays	2021
CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer. Scientific reports, 2021, 04-12, Volume: 11, Issue:1 Topics: Alternative Splicing; Animals; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinases; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; RNA-Seq; Thiazoles; Xenograft Model Antitumor Assays	2021
Inhibition of Midkine Suppresses Prostate Cancer CD133 The American journal of the medical sciences, 2017, Volume: 354, Issue:3 Topics: AC133 Antigen; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Gene Knockdown Techniques; Humans; Male; Midkine; Neoplastic Stem Cells; Nerve Growth Factors; Prostatic Neoplasms; RNA, Small Interfering; Thiazoles; Time Factors	2017
Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3. British journal of pharmacology, 2018, Volume: 175, Issue:11 Topics: Actin Depolymerizing Factors; Cell Survival; Cells, Cultured; Electric Stimulation; Humans; Lim Kinases; Male; Muscle Contraction; Muscle, Smooth; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Thiazoles	2018
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer. Cancer letters, 2018, 11-28, Volume: 437 Topics: Amino Acid Sequence; Binding Sites; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Imidazoles; Male; Mutation; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Domains; Protein Multimerization; Receptors, Androgen; Sequence Homology, Amino Acid; Small Molecule Libraries; Thiazoles	2018
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. Journal of the American Heart Association, 2018, 08-21, Volume: 7, Issue:16 Topics: Aged; Anticoagulants; Atrial Fibrillation; Comorbidity; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Neoplasms; Hemorrhage; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prostatic Neoplasms; Pyridines; Stroke; Thiazoles; Warfarin	2018
Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines. Journal of cellular physiology, 2019, Volume: 234, Issue:11 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Discoidin Domain Receptor 1; Epithelial-Mesenchymal Transition; Focal Adhesion Kinase 2; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 7; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tetrazolium Salts; Thiazoles	2019
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-23, Volume: 110, Issue:17 Topics: Analysis of Variance; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Genetic Vectors; HEK293 Cells; Humans; Immunoblotting; Immunoprecipitation; Lentivirus; Male; Mutation, Missense; Nuclear Proteins; Nuclear Receptor Coactivator 3; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles	2013
NVP-BEZ235, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, prominently enhances radiosensitivity of prostate cancer cell line PC-3. Cancer biotherapy & radiopharmaceuticals, 2013, Volume: 28, Issue:9 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Flow Cytometry; Humans; Imidazoles; Male; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Quinolines; Radiation Tolerance; Radiation, Ionizing; Radiopharmaceuticals; Receptors, Androgen; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases	2013
Vitamin K4 induces tumor cytotoxicity in human prostate carcinoma PC-3 cells via the mitochondria-related apoptotic pathway. Die Pharmazie, 2013, Volume: 68, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Flow Cytometry; Humans; Indicators and Reagents; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Prostatic Neoplasms; Reactive Oxygen Species; Spleen; Tetrazolium Salts; Thiazoles; Vitamin K 3	2013
Src controls castration recurrence of CWR22 prostate cancer xenografts. Cancer medicine, 2013, Volume: 2, Issue:6 Topics: Acetamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Dasatinib; HEK293 Cells; Humans; Male; Mice; Mice, Nude; Morpholines; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Pyrimidines; RNA, Small Interfering; src-Family Kinases; Thiazoles; Xenograft Model Antitumor Assays	2013
Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. Molecular cancer therapeutics, 2014, Volume: 13, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cholesterol; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NIH 3T3 Cells; Prostatic Neoplasms; Pyridines; Receptors, Androgen; Signal Transduction; Sterol Regulatory Element Binding Proteins; Thiazoles; Xenograft Model Antitumor Assays	2014
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. Oncotarget, 2014, Feb-15, Volume: 5, Issue:3 Topics: Aminophenols; Animals; Cell Growth Processes; Cell Line, Tumor; Dasatinib; Disease Progression; Enzyme Activation; Glycogen Synthase Kinase 3; Humans; Male; Maleimides; Mice; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Pyrimidines; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Thiazoles; Transfection	2014
Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor. Journal of medicinal chemistry, 2014, Aug-14, Volume: 57, Issue:15 Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Benzamides; Binding Sites; Cell Line, Tumor; Cell Survival; Computer Simulation; Databases, Chemical; DNA; Drug Resistance, Neoplasm; Humans; Imidazoles; Male; Molecular Conformation; Molecular Docking Simulation; Morpholines; Mutation; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrvinium Compounds; Rats; Receptors, Androgen; Structure-Activity Relationship; Thiazoles; Thiophenes; Transcription, Genetic	2014
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. The Journal of biological chemistry, 2014, Sep-19, Volume: 289, Issue:38 Topics: Active Transport, Cell Nucleus; Amino Acid Sequence; Androgen Receptor Antagonists; Animals; Binding Sites; Cell Nucleus; Chromatin; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; MCF-7 Cells; Mice, Nude; Molecular Sequence Data; Molecular Targeted Therapy; Prostatic Neoplasms; Protein Binding; Protein Isoforms; Receptors, Androgen; Thiazoles; Transcription, Genetic; Transcriptional Activation; Tumor Burden; Xenograft Model Antitumor Assays	2014
Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1. Oncotarget, 2014, Oct-30, Volume: 5, Issue:20 Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Lipid Metabolism; Male; Metribolone; Molecular Targeted Therapy; Phosphorylation; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pyridines; Silybin; Silymarin; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Thiazoles; Transfection	2014
Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition. International journal of cancer, 2015, Jun-15, Volume: 136, Issue:12 Topics: Blotting, Western; Boron Compounds; BRCA1 Protein; BRCA2 Protein; CDC2 Protein Kinase; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; DNA Breaks, Double-Stranded; DNA Repair; Histones; Homologous Recombination; Humans; Isoxazoles; Male; Microscopy, Fluorescence; Phosphorylation; Prostatic Neoplasms; PTEN Phosphohydrolase; Pyrimidines; Quinolines; Rad51 Recombinase; Receptor, IGF Type 1; RNA Interference; Thiazoles	2015
Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives. International journal of molecular sciences, 2014, Nov-24, Volume: 15, Issue:11 Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; CHO Cells; Cricetulus; Humans; Lethal Dose 50; Male; Prostatic Neoplasms; Pyrazoles; Pyrimidines; Thiazoles; Triazoles	2014
Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:3 Topics: Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Comet Assay; Diosmin; DNA Methylation; Humans; Male; Membrane Potential, Mitochondrial; Micronucleus Tests; Mutagens; Oxidative Stress; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles	2015
KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity. Journal of biomedical science, 2015, Jan-07, Volume: 22 Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase A; Cell Cycle; Cell Line; Humans; Male; Polymerization; Prostatic Hyperplasia; Prostatic Neoplasms; Thiazoles; Tubulin; Tubulin Modulators	2015
Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer. Pharmaceutical research, 2015, Volume: 32, Issue:8 Topics: Animals; Antineoplastic Agents, Hormonal; Cell Differentiation; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Delivery Systems; Estrogen Receptor alpha; Humans; Male; Mice; Mice, Nude; Necrosis; Particle Size; Prostate-Specific Antigen; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tissue Distribution; Toremifene	2015
Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells. Cellular and molecular life sciences : CMLS, 2015, Volume: 72, Issue:17 Topics: Analysis of Variance; Blotting, Western; Bromodeoxyuridine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dinoprostone; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microscopy, Fluorescence; Neovascularization, Pathologic; Phenotype; Prostatic Neoplasms; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Tetrazolium Salts; Thiazoles	2015
miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:5 Topics: Antineoplastic Agents; Blotting, Western; Coloring Agents; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Immunoprecipitation; Male; MicroRNAs; Neoplasm Invasiveness; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tissue Culture Techniques; Transcription Factors; Zinc Finger E-box-Binding Homeobox 1; Zinc Fingers	2015
Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. Journal of medicinal chemistry, 2015, Jun-11, Volume: 58, Issue:11 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Chromatography, High Pressure Liquid; Curcumin; Drug Design; Female; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Pentanones; Prostatic Neoplasms; Structure-Activity Relationship; Tandem Mass Spectrometry; Thiazoles; Tissue Distribution; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2015
Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America, 2015, Jul-07, Volume: 112, Issue:27 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lactams; Macrolides; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Prodrugs; Prostatic Neoplasms; Reactive Oxygen Species; Streptomyces; Thiazoles; Thiones	2015
Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. Oncotarget, 2015, Dec-01, Volume: 6, Issue:38 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Mutation; Prostatic Neoplasms; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sterol Regulatory Element Binding Proteins; Taxoids; Thiazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2015
Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 88 Topics: Aconitic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Coumarins; Curcumin; Docetaxel; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Synergism; Endocytosis; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Taxoids; Thiazoles	2017
Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model. The Prostate, 2017, Volume: 77, Issue:8 Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Drug Monitoring; Immunologic Factors; Inflammation; Injections, Intraperitoneal; Interleukin-17; Male; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Prostate; Prostatic Neoplasms; Sulfonamides; Th17 Cells; Thiazoles; Treatment Outcome	2017
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:4 Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Proliferation; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dimerization; Female; Humans; Male; Mice; Mice, SCID; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazoles; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2009
WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth. Cancer research, 2008, Jun-01, Volume: 68, Issue:11 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles	2008
Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells. European journal of pharmacology, 2008, Sep-28, Volume: 593, Issue:1-3 Topics: Adrenal Cortex Neoplasms; Androgen Receptor Antagonists; Androgens; Aromatase Inhibitors; Cell Line, Tumor; Cyclic AMP; Data Interpretation, Statistical; Genes, Reporter; Humans; Lactones; Luciferases; Male; Prostatic Neoplasms; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Transfection	2008
The orphan receptor ERRalpha interferes with steroid signaling. Nucleic acids research, 2008, Volume: 36, Issue:16 Topics: Androgens; Cell Line, Tumor; Drug Inverse Agonism; ERRalpha Estrogen-Related Receptor; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Response Elements; Signal Transduction; Thiazoles; Transcriptional Activation	2008
A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells. Acta pharmacologica Sinica, 2008, Volume: 29, Issue:9 Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Epithelial Cells; Genistein; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles	2008
Genomic strategy for targeting therapy in castration-resistant prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Apr-20, Volume: 27, Issue:12 Topics: Androgen Antagonists; Androgens; Dasatinib; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Humans; Male; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Orchiectomy; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thiazoles	2009
SRC family kinase activity is up-regulated in hormone-refractory prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10 Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Survival Analysis; Thiazoles; Up-Regulation	2009
Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer. Archiv der Pharmazie, 2009, Volume: 342, Issue:7 Topics: Antineoplastic Agents; Cell Death; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Nuclear Magnetic Resonance, Biomolecular; Prostatic Neoplasms; Structure-Activity Relationship; Thiazoles	2009
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. British journal of cancer, 2009, Jul-21, Volume: 101, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Neoplasms; Cell Line, Tumor; Dasatinib; Docetaxel; Humans; Male; Mice; Mice, SCID; Osteolysis; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Taxoids; Thiazoles; Xenograft Model Antitumor Assays	2009
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation. Cancer biology & therapy, 2009, Volume: 8, Issue:22 Topics: Adenocarcinoma; Animals; Bone Marrow Cells; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Collagen; Dasatinib; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Neoplasm Proteins; Osteoclasts; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; RANK Ligand; src-Family Kinases; Thiazoles	2009
Inhibition of prostate cancer by suicide gene targeting the FCY1 and HSV-TK genes. Oncology reports, 2009, Volume: 22, Issue:6 Topics: Cell Line, Tumor; Female; Genes, Transgenic, Suicide; Genetic Therapy; HeLa Cells; Humans; Male; Models, Genetic; Neoplasm Metastasis; Promoter Regions, Genetic; Prostatic Neoplasms; Simplexvirus; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Treatment Outcome	2009
Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Oncology reports, 2009, Volume: 22, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Early Growth Response Protein 1; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles	2009
Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system. International journal of pharmaceutics, 2010, Mar-15, Volume: 387, Issue:1-2 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Thiazines; Thiazoles; Time Factors	2010
Synthesis, formulation and in vitro evaluation of a novel microtubule destabilizer, SMART-100. Journal of controlled release : official journal of the Controlled Release Society, 2010, Apr-02, Volume: 143, Issue:1 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Proliferation; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Resistance, Neoplasm; Genes, Reporter; Hep G2 Cells; Humans; Inhibitory Concentration 50; Kinetics; Lactates; Liver Neoplasms; Luciferases; Male; Micelles; Polyethylene Glycols; Prostatic Neoplasms; Solubility; Technology, Pharmaceutical; Thiazoles; Tubulin Modulators	2010
Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol. Asian journal of andrology, 2010, Volume: 12, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contraceptive Agents, Male; Gossypol; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Microvilli; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays	2010
The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP. Asian journal of andrology, 2010, Volume: 12, Issue:3 Topics: Adenocarcinoma; Androgens; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation Tolerance; Tetrazolium Salts; Thiazoles	2010
Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. Oncogene, 2010, Jun-03, Volume: 29, Issue:22 Topics: Androgen Receptor Antagonists; Animals; Cell Growth Processes; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Dasatinib; Humans; Immunoblotting; Male; Mice; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thiazoles; Transfection; Xenograft Model Antitumor Assays	2010
Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chalcones; Cyclic AMP-Dependent Protein Kinases; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Humans; Male; Membrane Potentials; Mitochondrial Membranes; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Signal Transduction; Tetrazolium Salts; Thiazoles	2010
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. BMC cancer, 2010, Jun-01, Volume: 10 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-pim-1; Receptors, Androgen; RNA Interference; RNA, Messenger; Thiazoles; Time Factors; Transcriptional Activation; Transfection; Tumor Burden; Up-Regulation	2010
p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. The Prostate, 2011, Jan-01, Volume: 71, Issue:1 Topics: Aconitate Hydratase; Camptothecin; Carcinoma; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Mitochondria; Mutation; Prostatic Neoplasms; Response Elements; Thiazoles; Tumor Suppressor Protein p53	2011
FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line. Biochimica et biophysica acta, 2010, Volume: 1802, Issue:11 Topics: Antineoplastic Agents; Bufanolides; Cardenolides; Cardiac Glycosides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Humans; Inhibitory Concentration 50; Male; Molecular Structure; Ouabain; Principal Component Analysis; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared; Thiazoles; Time Factors	2010
The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells. The Journal of biological chemistry, 2010, Dec-10, Volume: 285, Issue:50 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Densitometry; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proteasome Endopeptidase Complex; Thiazoles; Ubiquitin	2010
Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor. Cancer research, 2011, Jan-01, Volume: 71, Issue:1 Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Melanoma; Mice; Mice, Inbred ICR; Microtubules; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Thiazoles; Transplantation, Heterologous	2011
Invasive prostate carcinoma driven by c-Src and androgen receptor synergy. Cancer research, 2011, Feb-01, Volume: 71, Issue:3 Topics: Animals; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Dasatinib; Epithelial-Mesenchymal Transition; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thiazoles; Up-Regulation	2011
Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro. Cell biology international, 2011, Volume: 35, Issue:11 Topics: Animals; Apoptosis; Blotting, Western; Calcium; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Gadolinium; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Microscopy, Confocal; Osteoclasts; Phosphorylation; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Wound Healing	2011
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression. Cancer biology & therapy, 2011, Aug-15, Volume: 12, Issue:4 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoblotting; Male; Microscopy, Fluorescence; NF-kappa B; PPAR gamma; Prostatic Neoplasms; Resting Phase, Cell Cycle; RNA Interference; Thiazoles; Thiazolidinediones; Troglitazone; Urea	2011
Role of vimentin in the inhibitory effects of low-molecular-weight heparin on PC-3M cell adhesion to, and migration through, endothelium. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1 Topics: Blotting, Western; Calcium; Cell Adhesion; Cell Movement; Cell Survival; Cells, Cultured; Coloring Agents; Electrophoresis, Gel, Two-Dimensional; Endothelium, Vascular; Fluorescent Antibody Technique; Heparin, Low-Molecular-Weight; Humans; Male; Microscopy, Electron, Scanning; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Surface Plasmon Resonance; Tetrazolium Salts; Thiazoles; Vimentin	2011
Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells. Clinical & experimental metastasis, 2012, Volume: 29, Issue:2 Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dasatinib; Humans; Male; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Metastasis; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles	2012
Mn-doped ZnSe d-dots-based α-methylacyl-CoA racemase probe for human prostate cancer cell imaging. Analytical and bioanalytical chemistry, 2012, Volume: 402, Issue:5 Topics: Androgens; Biomarkers, Tumor; Cadmium; Cell Line, Tumor; Cell Survival; Humans; Male; Manganese; Prostatic Neoplasms; Quantum Dots; Racemases and Epimerases; Selenium Compounds; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Zinc Compounds	2012
Transitional cell carcinoma involving the ductus deferens in a dog. Journal of the American Veterinary Medical Association, 2012, Feb-15, Volume: 240, Issue:4 Topics: Animals; Carcinoma, Transitional Cell; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Euthanasia, Animal; Male; Meloxicam; Prostatic Neoplasms; Testicular Neoplasms; Thiazines; Thiazoles; Vas Deferens	2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proceedings of the National Academy of Sciences of the United States of America, 2012, Sep-11, Volume: 109, Issue:37 Topics: Animals; Calcium-Binding Proteins; Cell Line, Tumor; Cell Movement; Disease Progression; DNA Primers; Extracellular Matrix Proteins; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Male; Mice; Mice, Mutant Strains; Microarray Analysis; Models, Biological; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; Tetrazolium Salts; Thiazoles	2012
Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PloS one, 2012, Volume: 7, Issue:10 Topics: Acetylation; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Histone Acetyltransferases; Histones; Humans; Inhibitory Concentration 50; Lysine Acetyltransferase 5; Male; Models, Chemical; Molecular Structure; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Radiation, Ionizing; RNA Interference; Thiazoles; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2012
The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism. British journal of pharmacology, 2013, Volume: 168, Issue:6 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Fingolimod Hydrochloride; Free Radical Scavengers; Humans; Isoenzymes; Male; Neoplasm Proteins; Oxidative Stress; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Stability; Receptors, Androgen; RNA, Messenger; Sphingosine; Thiazoles	2013
The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species. Journal of natural medicines, 2013, Volume: 67, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Indoles; Male; Neoplasm Invasiveness; Oxidative Stress; Phytoalexins; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Reactive Oxygen Species; RNA Interference; Sesquiterpenes; Snail Family Transcription Factors; Thiazoles; Time Factors; Transcription Factors; Transfection	2013
Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis. Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:1 Topics: Animal Feed; Animals; Cell Line, Tumor; Cell Survival; Diet; Humans; Immunohistochemistry; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Mutation; Phosphorylation; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Resveratrol; Ribosomal Protein S6 Kinases; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors; TOR Serine-Threonine Kinases	2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. PloS one, 2012, Volume: 7, Issue:12 Topics: Animals; Apoptosis; Blotting, Western; Bone Diseases; Cell Cycle; Cell Proliferation; Dasatinib; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; Male; Mice; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction; src-Family Kinases; Thiazoles; Triazines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2012
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer. The Prostate, 2013, Volume: 73, Issue:9 Topics: 3T3 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dasatinib; Docetaxel; Enzyme-Linked Immunosorbent Assay; Humans; Insulin-Like Growth Factor I; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Osteoblasts; Prostatic Neoplasms; Pyrimidines; Taxoids; Thiazoles; Xenograft Model Antitumor Assays	2013
Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. The Journal of biological chemistry, 2002, Dec-20, Volume: 277, Issue:51 Topics: Active Transport, Cell Nucleus; Arachidonic Acid; Catalysis; Cell Nucleus; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Endothelial Growth Factors; Enzyme Inhibitors; Flavonoids; Green Fluorescent Proteins; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Intercellular Signaling Peptides and Proteins; Isoenzymes; Luminescent Proteins; Lymphokines; Male; MAP Kinase Signaling System; Meloxicam; Membrane Proteins; Nitrobenzenes; Phosphatidylinositol 3-Kinases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Thiazines; Thiazoles; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Molecular cancer therapeutics, 2002, Volume: 1, Issue:14 Topics: Actins; Apoptosis; CCAAT-Enhancer-Binding Proteins; Coloring Agents; Cyclophilins; DNA; Drug Design; GADD45 Proteins; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Kinetics; Male; Models, Chemical; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Prostatic Neoplasms; Proteins; RNA, Messenger; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Time Factors; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured; Up-Regulation	2002
Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:1 Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Nucleus; Coloring Agents; Disease Progression; DNA-Binding Proteins; Humans; Interleukin-6; Male; Mice; Phenotype; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured	2003
Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:3 Topics: Adenoviridae; Animals; Apoptosis; Blotting, Western; Caspase 9; Caspases; Cell Death; Cell Line; Coloring Agents; Down-Regulation; Fever; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Plasmids; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured	2003
Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells. Journal of cellular physiology, 2003, Volume: 196, Issue:1 Topics: Adenocarcinoma; Cell Division; Gene Expression Regulation, Neoplastic; Humans; Male; Phenotype; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tumor Cells, Cultured	2003
Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP. FEBS letters, 2003, Jun-05, Volume: 544, Issue:1-3 Topics: Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Death; Coloring Agents; Free Radical Scavengers; Humans; Indoles; Male; Membrane Glycoproteins; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2003
IL-18 is produced by prostate cancer cells and secreted in response to interferons. International journal of cancer, 2003, Oct-10, Volume: 106, Issue:6 Topics: Antineoplastic Agents; Caspase 1; Caspase Inhibitors; Cell Division; Cohort Studies; DNA Primers; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Interferon-alpha; Interferon-gamma; Interleukin-18; Interleukin-18 Receptor alpha Subunit; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Interleukin; Receptors, Interleukin-18; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2003
[EVALUATION OF THE THERAPEUTIC EFFECTIVENESS OF 2-ACETAMIDO-4-(5-NITRO-2FURYL)-THIAZOLE. CLINICAL CASES]. Minerva medica, 1963, Aug-29, Volume: 54 Topics: Epididymitis; Humans; Male; Nitrofurans; Orchitis; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Sepsis; Thiazoles; Thrombophlebitis; Urinary Bladder Neoplasms; Urinary Tract Infections	1963
PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. International journal of oncology, 2003, Volume: 23, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Nucleus; Coloring Agents; Down-Regulation; Drugs, Chinese Herbal; Genes, Dominant; Humans; Luciferases; Male; Models, Genetic; Phosphorylation; Plasmids; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Structure, Tertiary; Receptors, Androgen; Response Elements; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transcription, Genetic; Transfection	2003
Effects of phenformin on the proliferation of human tumor cell lines. Life sciences, 2003, Dec-19, Volume: 74, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Culture Media; Glucose; Humans; Hypoglycemic Agents; Male; Neuroblastoma; Oncogene Protein p21(ras); Phenformin; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles	2003
Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer gene therapy, 2004, Volume: 11, Issue:3 Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytosine Deaminase; Escherichia coli; Flucytosine; Ganciclovir; Gene Transfer Techniques; Genes, Transgenic, Suicide; Genetic Therapy; Herpesvirus 1, Human; Male; Prostatic Neoplasms; Rats; Recombinant Fusion Proteins; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Toxicity Tests; Tumor Stem Cell Assay	2004
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4 Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome	2004
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. Cancer research, 2004, May-01, Volume: 64, Issue:9 Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression; Genes, cdc; Genes, Reporter; Humans; Ligands; Luciferases; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Response Elements; RNA, Messenger; Signal Transduction; Thiazoles; Transcription Factors; Transcriptional Activation	2004
Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxidants & redox signaling, 2004, Volume: 6, Issue:3 Topics: Adenocarcinoma; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Complementary; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Humans; Male; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Phenotype; Plasmids; Prostatic Neoplasms; Rats; Sodium Selenite; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Transfection	2004
Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. International journal of cancer, 2004, Jul-10, Volume: 110, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Histones; Humans; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Male; Mitosis; Models, Chemical; Plant Extracts; Ploidies; Prostatic Neoplasms; Quinazolines; Tetrazolium Salts; Thiazoles; Time Factors	2004
Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. The Journal of biological chemistry, 2004, Jul-30, Volume: 279, Issue:31 Topics: Animals; Catalysis; Cell Division; Cell Line, Tumor; COS Cells; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Male; Phosphorylation; Plasmids; Prostatic Neoplasms; Protein Structure, Tertiary; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transcriptional Activation; Transfection	2004
Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. The Journal of urology, 2004, Volume: 172, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 3; Caspases; Cell Division; Coloring Agents; Dose-Response Relationship, Drug; Flavanones; Flow Cytometry; Humans; Ibuprofen; In Situ Nick-End Labeling; Male; Nitrates; Nitric Oxide Donors; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2004
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Molecular cancer therapeutics, 2004, Volume: 3, Issue:7 Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzothiazoles; Caspase Inhibitors; Caspases; Cell Line, Tumor; Enzyme Activation; Humans; Male; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Serine; Sodium Selenite; Thiazoles; Toluene; Tumor Suppressor Protein p53	2004
Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Molecular cancer therapeutics, 2004, Volume: 3, Issue:8 Topics: Alkaloids; Antioxidants; Apoptosis; Benzophenanthridines; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclin-Dependent Kinases; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Isoquinolines; Keratinocytes; Male; Models, Biological; Models, Chemical; Plant Extracts; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles	2004
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase. International journal of cancer, 2004, Oct-20, Volume: 112, Issue:1 Topics: Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Division; Humans; Hydroxyeicosatetraenoic Acids; Linoleic Acid; Male; Neoplasms, Hormone-Dependent; Nerve Tissue Proteins; Nuclear Receptor Subfamily 1, Group F, Member 1; Prostatic Neoplasms; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiosemicarbazones; Trans-Activators; Tumor Cells, Cultured	2004
Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth. International journal of cancer, 2004, Dec-20, Volume: 112, Issue:6 Topics: Antineoplastic Agents; Benzothiazoles; Bone Morphogenetic Proteins; Calcitriol; Calcium Channel Agonists; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Dihydrotestosterone; DNA, Complementary; DNA, Neoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Male; Membrane Proteins; Prostatic Neoplasms; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thiazoles; Toluene; Vanadates	2004
Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Bioorganic & medicinal chemistry letters, 2004, Nov-01, Volume: 14, Issue:21 Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms; Structure-Activity Relationship; Thiazoles	2004
Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells. European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3 Topics: Apoptosis; Blotting, Western; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Diterpenes; Diterpenes, Clerodane; Enzyme Activation; Fas Ligand Protein; Genes, bcl-2; Humans; In Situ Nick-End Labeling; Male; Membrane Glycoproteins; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Signal Transduction; Tetrazolium Salts; Thiazoles	2004
CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line. The Journal of biological chemistry, 2005, Jan-28, Volume: 280, Issue:4 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Coloring Agents; Cyclin B; Cyclin B1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Male; Microscopy, Fluorescence; Microtubule-Associated Proteins; Microtubules; Mitosis; Neoplasm Metastasis; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Survivin; Tetrazolium Salts; Thiazoles; Time Factors; Up-Regulation	2005
Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy. Cancer gene therapy, 2005, Volume: 12, Issue:3 Topics: Adenocarcinoma; Adenoviridae; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Endothelial Cells; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neovascularization, Pathologic; Osteocalcin; Promoter Regions, Genetic; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-2	2005
Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines. The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:1 Topics: Androgen Antagonists; Androgens; Anilides; Blotting, Western; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; Genes, p53; Humans; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA; Telomerase; Tetrazolium Salts; Thiazoles; Tosyl Compounds	2005
Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene, 2005, May-05, Volume: 24, Issue:20 Topics: Adenoviridae; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coloring Agents; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genetic Vectors; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Immunoblotting; Male; NF-kappa B; Oxidative Stress; Prostatic Neoplasms; Retroviridae; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Time Factors	2005
Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7 Topics: Amides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship; Thiazoles	2005
IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation. Cellular signalling, 2005, Volume: 17, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Benzimidazoles; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Densitometry; Disease Progression; Enzyme Activation; Epithelial Cells; Fenretinide; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Neurons; Neurosecretory Systems; Phenotype; Plasmids; Prostate; Prostatic Neoplasms; Rats; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Synaptophysin; Tetrazolium Salts; Thiazoles; Tissue Distribution; Transcription Factors; Transcription, Genetic; Up-Regulation	2005
Antioxidant activity and antiproliferative action of methanolic extract of Geum quellyon Sweet roots in human tumor cell lines. Journal of ethnopharmacology, 2005, Sep-14, Volume: 100, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Biphenyl Compounds; Caco-2 Cells; Cell Line, Tumor; Chelating Agents; Chile; Comet Assay; DNA, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Free Radical Scavengers; Geum; Humans; Hydrazines; Hydrogen Peroxide; KB Cells; L-Lactate Dehydrogenase; Male; Medicine, Traditional; Picrates; Plant Extracts; Plant Roots; Prostatic Neoplasms; Reactive Oxygen Species; Tannins; Tetrazolium Salts; Thiazoles; Ultraviolet Rays; Xanthine Oxidase	2005
Antitumor effect of antisense ODC adenovirus on human prostate cancer cells. Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:3 Topics: Adenoviridae; Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Chromatography, High Pressure Liquid; Collagen; Drug Combinations; Flow Cytometry; G1 Phase; Gene Transfer Techniques; Genetic Therapy; Humans; Laminin; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oligonucleotides, Antisense; Polyamines; Prostatic Neoplasms; Proteoglycans; Resting Phase, Cell Cycle; Tetrazolium Salts; Thiazoles; Time Factors	2005
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. The Journal of biological chemistry, 2005, Oct-28, Volume: 280, Issue:43 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix; Gene Silencing; Humans; Immunoblotting; Laminin; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plasmids; Prostatic Neoplasms; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Urokinase-Type Plasminogen Activator	2005
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer research, 2005, Oct-15, Volume: 65, Issue:20 Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles	2005
Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound. The Prostate, 2006, Mar-01, Volume: 66, Issue:4 Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Thiazoles; Thiazolidines; Tumor Cells, Cultured	2006
Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-alpha-aminophosphonates. Bioorganic & medicinal chemistry letters, 2006, Mar-15, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Benzothiazoles; Cell Proliferation; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Melanoma; Organophosphonates; Prohibitins; Prostatic Neoplasms; Skin Neoplasms; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured	2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line. BMC cancer, 2006, Jan-24, Volume: 6 Topics: Antimitotic Agents; Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Primers; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genistein; Histones; Humans; Isoflavones; Kinesins; Male; Models, Statistical; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Spindle Apparatus; Tetrazolium Salts; Thiazoles	2006
The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells. Bioorganic & medicinal chemistry, 2006, Oct-01, Volume: 14, Issue:19 Topics: Actins; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclohexane Monoterpenes; Cyclohexenes; Extracellular Signal-Regulated MAP Kinases; Farnesyltranstransferase; Humans; Indicators and Reagents; Limonene; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mitogen-Activated Protein Kinases; Monoterpenes; Prostatic Neoplasms; Signal Transduction; Structure-Activity Relationship; Terpenes; Tetrazolium Salts; Thiazoles	2006
Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2007, Volume: 45, Issue:2 Topics: Absorption; Animals; Anticarcinogenic Agents; Cadmium; Catechin; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Male; Prostatic Neoplasms; Spectrophotometry, Atomic; Spectrophotometry, Ultraviolet; Tea; Tetrazolium Salts; Thiazoles; Time Factors; Zinc	2007
Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. European journal of medicinal chemistry, 2007, Volume: 42, Issue:3 Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Thiazoles	2007
Novel structural motifs consisting of chiral thiazolines: synthesis, molecular recognition, and anticancer activity. Chemistry (Weinheim an der Bergstrasse, Germany), 2007, Volume: 13, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Survival; Colorectal Neoplasms; Humans; Macrocyclic Compounds; Male; Molecular Structure; Pancreatic Neoplasms; Prostatic Neoplasms; Thiazoles; Tumor Cells, Cultured	2007
Antitumor properties of diastereomeric and geometric analogs of vitamin D3. Anti-cancer drugs, 2007, Volume: 18, Issue:4 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Calcitriol; Calcium; Carcinoma, Lewis Lung; CD11b Antigen; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Coloring Agents; Female; Fibroblasts; HL-60 Cells; Humans; Lipopolysaccharide Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pancreatic Neoplasms; Prostatic Neoplasms; Rhodamines; Stereoisomerism; Tetrazolium Salts; Thiazoles	2007
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents. Bioorganic & medicinal chemistry, 2007, May-15, Volume: 15, Issue:10 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents; Blotting, Western; Catalysis; Cell Line, Tumor; Computational Biology; Databases, Factual; Dose-Response Relationship, Drug; Down-Regulation; Humans; Male; Models, Molecular; Neoplasm Proteins; Prostatic Neoplasms; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles	2007
Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:6 Topics: Apoptosis; bcl-X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Flow Cytometry; Green Fluorescent Proteins; Humans; In Situ Nick-End Labeling; Luciferases; Male; Neoplasm Transplantation; Plasmids; Promoter Regions, Genetic; Prostatic Neoplasms; Radiation-Sensitizing Agents; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tetrazolium Salts; Thiazoles; Transfection; Transplantation, Heterologous; Tumor Stem Cell Assay	2008
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. The Prostate, 2007, Nov-01, Volume: 67, Issue:15 Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Ceramides; Down-Regulation; Enzyme Inhibitors; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Thiazoles	2007
Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome biology, 2007, Volume: 8, Issue:11 Topics: Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Dasatinib; Gene Expression Profiling; Humans; Male; Monitoring, Physiologic; Patient Selection; Prostatic Neoplasms; Pyrimidines; Thiazoles; Treatment Outcome	2007
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:6 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers; Cell Division; Dasatinib; Drug Monitoring; Female; Humans; Leukocytes, Mononuclear; Male; Mice; Mice, Nude; Neoplasm Proteins; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Specific Pathogen-Free Organisms; src-Family Kinases; Substrate Specificity; Thiazoles; Xenograft Model Antitumor Assays	2008
Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer research, 2008, May-01, Volume: 68, Issue:9 Topics: Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Crk-Associated Substrate Protein; Dasatinib; Disease Models, Animal; Drug Delivery Systems; Focal Adhesion Kinase 1; Humans; Lymphatic Metastasis; Male; Mice; Mice, Nude; Prostatic Neoplasms; Pyrimidines; src-Family Kinases; Thiazoles; Tumor Burden; Tumor Cells, Cultured; Tyrosine; Xenograft Model Antitumor Assays	2008
Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:1 Topics: Amino Acid Sequence; Androgens; Base Sequence; Cell Division; Coloring Agents; Dihydrotestosterone; DNA, Neoplasm; Epidermal Growth Factor; Exons; Fibroblast Growth Factor 2; Humans; Male; Metribolone; Molecular Sequence Data; Molecular Weight; Neoplasm Proteins; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Testosterone Congeners; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1995
Scanning electron microscopy and transmission electron microscopy aspects of synergistic antitumor activity of vitamin C - vitamin K3 combinations against human prostatic carcinoma cells. Scanning microscopy, 1995, Volume: 9, Issue:1 Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma; Cell Membrane; Coloring Agents; Cytoskeleton; Drug Synergism; Drug Therapy, Combination; Humans; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Mitochondria; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vitamin K	1995
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. British journal of cancer, 1998, Volume: 77, Issue:5 Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Carcinoma; Cell Cycle; Colonic Neoplasms; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estrogens; Female; Growth Inhibitors; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Skin Neoplasms; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured	1998
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer research, 1998, Aug-01, Volume: 58, Issue:15 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Differentiation; Chromans; Drug Synergism; Humans; Ligands; Male; Mice; Mice, Nude; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured	1998
Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies. Experimental and molecular pathology, 1999, Volume: 67, Issue:1 Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Binding Sites, Antibody; Breast Neoplasms; Cell Transformation, Neoplastic; Cross Reactions; Epitopes; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunoglobulin Variable Region; Male; Mice; Models, Molecular; Prostatic Neoplasms; Rats; Receptor, ErbB-2; Tetrazolium Salts; Thiazoles; Trastuzumab	1999
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer research, 2000, Oct-01, Volume: 60, Issue:19 Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents; Blotting, Western; Chromans; Dihydrotestosterone; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Ligands; Male; Middle Aged; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Response Elements; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone	2000
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2000
Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer research, 2000, Dec-15, Volume: 60, Issue:24 Topics: alpha Catenin; Animals; beta Catenin; Cadherins; Cell Adhesion; Cell Communication; Cell Division; Cell Survival; Coloring Agents; Contact Inhibition; Cytoplasm; Cytoskeletal Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Genes, Reporter; Immunoblotting; Male; Mice; Mutation; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Protein Structure, Tertiary; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Transcription, Genetic; Transfection	2000
15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer research, 2001, Jan-15, Volume: 61, Issue:2 Topics: Agar; Arachidonate 15-Lipoxygenase; Blotting, Northern; Catalysis; Cell Division; Culture Media; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydroxyeicosatetraenoic Acids; Isoenzymes; Luciferases; Male; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured	2001
Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxidants & redox signaling, 1999,Spring, Volume: 1, Issue:1 Topics: Antimycin A; Coloring Agents; DNA; Electron Transport; Fluoresceins; Fluorescent Dyes; Humans; Hydroxyl Radical; Male; Metribolone; Mitochondria; Oxidative Stress; Peroxides; Prostatic Neoplasms; Rotenone; Testosterone Congeners; Tetrazolium Salts; Thiazoles; Time Factors; Tocopherols; Tumor Cells, Cultured; Uncoupling Agents; Vitamin E	1999
Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells. The Prostate, 2001, Mar-01, Volume: 46, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Ligands; Male; Mice; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 1; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiosemicarbazones; Trans-Activators; Transplantation, Heterologous; Tumor Cells, Cultured	2001
Other novel agents: Rationale and current status as chemopreventive agents. Urology, 2001, Volume: 57, Issue:4 Suppl 1 Topics: Anticarcinogenic Agents; Atrasentan; Chromans; Humans; Male; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Somatomedins; Thiazoles; Thiazolidinediones; Troglitazone; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors	2001
Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells. International journal of cancer, 2001, Jun-01, Volume: 92, Issue:5 Topics: Androgens; Antineoplastic Agents; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Humans; Male; Neoplasms, Hormone-Dependent; Nuclear Receptor Subfamily 1, Group F, Member 1; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiosemicarbazones; Trans-Activators; Tumor Cells, Cultured	2001
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:3 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Northern; Clusterin; Electrophoresis, Capillary; Glycoproteins; Half-Life; Humans; Male; Mice; Molecular Chaperones; Neoplasm Proteins; Oligonucleotides, Antisense; Paclitaxel; Prostatic Neoplasms; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2001
Regulation of u-PA gene expression in human prostate cancer. International journal of cancer, 2001, Nov-01, Volume: 94, Issue:3 Topics: Blotting, Northern; Blotting, Western; Cell Division; Chloramphenicol O-Acetyltransferase; Coloring Agents; Down-Regulation; Flutamide; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Male; MAP Kinase Signaling System; Mutation; Promoter Regions, Genetic; Prostatic Neoplasms; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator	2001
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. The Journal of biological chemistry, 2002, Mar-01, Volume: 277, Issue:9 Topics: Amino Acids; Anilides; Blotting, Northern; Colforsin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Immunoblotting; Interleukin-6; Janus Kinase 1; Luciferases; Male; MAP Kinase Signaling System; Models, Biological; Nitriles; Phosphorylation; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Tosyl Compounds; Trans-Activators; Transcriptional Activation; Transfection; Tumor Cells, Cultured	2002
Anticancer cytotoxicity and nephrotoxicity of the new platinum (II) complexes containing diaminocyclohexane and glycolic acid. International journal of oncology, 2002, Volume: 20, Issue:5 Topics: Animals; Antineoplastic Agents; Cells, Cultured; Coloring Agents; Cyclohexanes; DNA; Female; Glucose; Glycolates; Humans; Kidney Cortex; Ligands; Male; Models, Chemical; Ovarian Neoplasms; Platinum Compounds; Prostatic Neoplasms; Rabbits; Tetrazolium Salts; Thiazoles; Thymidine; Time Factors; Tumor Cells, Cultured	2002
Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. International journal of oncology, 2002, Volume: 20, Issue:5 Topics: Acridine Orange; Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Prostatic Neoplasms; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Human gene therapy, 2002, May-01, Volume: 13, Issue:7 Topics: Acyclovir; Animals; Antiviral Agents; Apoptosis; Binding Sites; Blotting, Southern; Blotting, Western; Disease Progression; Dose-Response Relationship, Drug; Flow Cytometry; Ganciclovir; Genetic Therapy; Green Fluorescent Proteins; Guanosine; Humans; Luminescent Proteins; Male; Mice; Mice, SCID; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Prodrugs; Propidium; Prostatic Neoplasms; Simplexvirus; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Tomography, Emission-Computed; Tumor Cells, Cultured	2002
Application of the chemiluminescent assay to cytotoxicity test: detection of menadione-catalyzed H2O2 production by viable cells. Analytical biochemistry, 1992, Volume: 207, Issue:2 Topics: 3T3 Cells; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Count; Cell Line; Cell Survival; Coloring Agents; Humans; Hydrogen Peroxide; Indicators and Reagents; Luminescent Measurements; Male; Mice; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tomatine; Tumor Cells, Cultured; Vitamin K	1992
Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer research, 1991, Dec-15, Volume: 51, Issue:24 Topics: Biological Transport; Calcium; Carcinoma; Cell Division; Energy Metabolism; Epidermal Growth Factor; Humans; In Vitro Techniques; Male; Microscopy, Electron; Mitochondria; Oxidoreductases; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Suramin; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1991
Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984. The Prostate, 1989, Volume: 15, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Basement Membrane; Disease Models, Animal; Epithelium; Male; Prostatic Neoplasms; Rats; Thiazoles; Thiazolidines; Tumor Cells, Cultured	1989
Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. The Prostate, 1988, Volume: 12, Issue:1 Topics: Androgens; Cell Count; Cell Division; Coloring Agents; Drug Screening Assays, Antitumor; Eflornithine; Estrenes; Humans; Male; Metribolone; Mitoguazone; Oxidation-Reduction; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1988
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion. Cancer research, 1986, Volume: 46, Issue:4 Pt 1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Corticosterone; Female; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Thiazoles; Thiazolidines	1986